(Q35779227)

10 August 2017

1 reference

title

Etanercept: a clinical review of current and emerging indications (English)

1 reference

10 August 2017

Shikha Nanda

1

1 reference

10 August 2017

Joan M Bathon

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

1175-1186

1 reference

The tumor necrosis factor ligand and receptor families.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Etanercept in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Inflammatory bowel disease: new insights into pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Etanercept therapy in children with treatment-resistant uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.5.1175

10.1517/14656566.5.5.1175

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference